Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This appears to be a combination of two separate drugs: **Pentamidine** is an antifungal agent primarily used to treat and prevent Pneumocystis carinii pneumonia (PCP), a serious type of pneumonia that commonly occurs in patients with compromised immune systems, such as those with HIV/AIDS. It can be administered via injection or inhalation. **Sodium cromoglycate** (also known as cromolyn sodium) is a mast cell stabilizer that prevents the release of inflammatory mediators like histamine and leukotrienes. It is used for the prophylactic management of asthma, allergic rhinitis, and other allergic conditions. It has no intrinsic bronchodilator, antihistaminic, or anti-inflammatory activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on pentamidine + sodium cromoglycate.